{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:03:29Z","timestamp":1767956609033,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"DOI":"10.7759\/cureus.101140","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:29:36Z","timestamp":1767950976000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Detour: A Case of Opsoclonus-Myoclonus-Ataxia Syndrome Initially Misdiagnosed As Tricyclic Antidepressant Toxicity in a Child"],"prefix":"10.7759","author":[{"given":"Yousef M","family":"Al-Shammari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaikhah M","family":"Al-Shammari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan  Y","family":"BuAbbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omnia  A","family":"Mahsoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talal A","family":"Al-Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00468","article-title":"Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study","volume":"8","author":"Pranzatelli MR","year":"2017","unstructured":"Pranzatelli MR, Tate ED, McGee NR. Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study. Front Neurol. 2017, 8:468. 10.3389\/fneur.2017.00468","journal-title":"Front Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.4607","article-title":"Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies","volume":"73","author":"Armangu\u00e9 T","year":"2016","unstructured":"Armangu\u00e9 T, Sabater L, Torres-Vega E, et al.. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol. 2016, 73:417-24. 10.1001\/jamaneurol.2015.4607","journal-title":"JAMA Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0883073814549581","article-title":"Effect of increased immunosuppression on developmental outcome of opsoclonus myoclonus syndrome (OMS)","volume":"30","author":"Mitchell WG","year":"2015","unstructured":"Mitchell WG, Wooten AA, O'Neil SH, Rodriguez JG, Cruz RE, Wittern R. Effect of increased immunosuppression on developmental outcome of opsoclonus myoclonus syndrome (OMS). J Child Neurol. 2015, 30:976-82. 10.1177\/0883073814549581","journal-title":"J Child Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001153","article-title":"Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective","volume":"9","author":"Rossor T","year":"2022","unstructured":"Rossor T, Yeh EA, Khakoo Y, et al.. Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective. Neurol Neuroimmunol Neuroinflamm. 2022, 9:e1153. 10.1212\/NXI.0000000000001153","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112879","article-title":"Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma","volume":"42","author":"Rosenberg MI","year":"2023","unstructured":"Rosenberg MI, Greenstein E, Buchkovich M, et al.. Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma. Cell Rep. 2023, 42:112879. 10.1016\/j.celrep.2023.112879","journal-title":"Cell Rep"},{"key":"ref6","unstructured":"Mitchell Pike OMS rating scales full - from Wendy Mitchell. (2017). Accessed. 2025: https:\/\/omslifefoundation.org\/mitchell-pike-oms-rating-scales-full-from-wendy-mitchell-sept-15-2017\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(17)30130-X","article-title":"Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial","volume":"2","author":"De Alarcon PA","year":"2018","unstructured":"De Alarcon PA, Matthay KK, London WB, et al.. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc Health. 2018, 2:25-34. 10.1016\/S2352-4642(17)30130-X","journal-title":"Lancet Child Adolesc Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2016.59.6.252","article-title":"Pneumocystis jirovecii pneumonia in pediatric patients: an analysis of 15 confirmed consecutive cases during 14 years","volume":"59","author":"Kim KR","year":"2016","unstructured":"Kim KR, Kim JM, Kang JM, Kim YJ. Pneumocystis jirovecii pneumonia in pediatric patients: an analysis of 15 confirmed consecutive cases during 14 years. Korean J Pediatr. 2016, 59:252-5. 10.3345\/kjp.2016.59.6.252","journal-title":"Korean J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701226192","article-title":"Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management","volume":"45","author":"Woolf AD","year":"2007","unstructured":"Woolf AD, Erdman AR, Nelson LS, et al.. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007, 45:203-33. 10.1080\/15563650701226192","journal-title":"Clin Toxicol (Phila)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200524030-00013","article-title":"Tricyclic antidepressant poisoning: cardiovascular toxicity","volume":"24","author":"Thanacoody HK","year":"2005","unstructured":"Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev. 2005, 24:205-14. 10.2165\/00139709-200524030-00013","journal-title":"Toxicol Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel AR","year":"2017","unstructured":"Tunkel AR, Hasbun R, Bhimraj A, et al.. 2017 Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017, 64:e34-65. 10.1093\/cid\/ciw861","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus F","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al.. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016, 15:391-404. 10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27097","article-title":"Multifactorial analysis of opsoclonus-myoclonus syndrome etiology (\u201ctumor\u201d vs. \u201cno tumor\u201d) in a cohort of 356 US children","volume":"65","author":"Pranzatelli MR","year":"2018","unstructured":"Pranzatelli MR, Tate ED, McGee NR. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology (\u201ctumor\u201d vs. \u201cno tumor\u201d) in a cohort of 356 US children. Pediatr Blood Cancer. 2018, 65:e27097. 10.1002\/pbc.27097","journal-title":"Pediatr Blood Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/children11030367","article-title":"Review of opsoclonus-myoclonus ataxia syndrome in pediatric patients","volume":"11","author":"Hsu M","year":"2024","unstructured":"Hsu M, Tejani I, Shah N, Olaosebikan R, Kumar A, Naik S. Review of opsoclonus-myoclonus ataxia syndrome in pediatric patients. Children (Basel). 2024, 11:367. 10.3390\/children11030367","journal-title":"Children (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10536-3","article-title":"Opsoclonus-myoclonus-ataxia syndrome in children","volume":"269","author":"Bhatia P","year":"2022","unstructured":"Bhatia P, Heim J, Cornejo P, Kane L, Santiago J, Kruer MC. Opsoclonus-myoclonus-ataxia syndrome in children. J Neurol. 2022, 269:750-7. 10.1007\/s00415-021-10536-3","journal-title":"J Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.62.9.1526","article-title":"B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli MR","year":"2004","unstructured":"Pranzatelli MR, Travelstead AL, Tate ED, et al.. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology. 2004, 62:1526-32. 10.1212\/wnl.62.9.1526","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2011.02.012","article-title":"Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus","volume":"45","author":"Pranzatelli MR","year":"2011","unstructured":"Pranzatelli MR, Slev PR, Tate ED, Travelstead AL, Colliver JA, Joseph SA. Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus. Pediatr Neurol. 2011, 45:27-33. 10.1016\/j.pediatrneurol.2011.02.012","journal-title":"Pediatr Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-10","article-title":"BAFF\/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy","volume":"10","author":"Pranzatelli MR","year":"2013","unstructured":"Pranzatelli MR, Tate ED, McGee NR, Travelstead AL, Colliver JA, Ness JM, Ransohoff RM. BAFF\/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. J Neuroinflammation. 2013, 10:806. 10.1186\/1742-2094-10-10","journal-title":"J Neuroinflammation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-009-9335-3","article-title":"Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus","volume":"30","author":"Pranzatelli MR","year":"2010","unstructured":"Pranzatelli MR, Tate ED, Travelstead AL, Colliver JA. Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus. J Clin Immunol. 2010, 30:106-13. 10.1007\/s10875-009-9335-3","journal-title":"J Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2007.05.005","article-title":"Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses","volume":"12","author":"Wilken B","year":"2008","unstructured":"Wilken B, Baumann M, Bien CG, Hero B, Rostasy K, Hanefeld F. Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses. Eur J Paediatr Neurol. 2008, 12:51-5. 10.1016\/j.ejpn.2007.05.005","journal-title":"Eur J Paediatr Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2023.12.001","article-title":"Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes","volume":"180","author":"Villagr\u00e1n-Garc\u00eda M","year":"2024","unstructured":"Villagr\u00e1n-Garc\u00eda M, Farina A, Campetella L, Arzalluz-Luque J, Honnorat J. Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes. Rev Neurol (Paris). 2024, 180:107-16. 10.1016\/j.neurol.2023.12.001","journal-title":"Rev Neurol (Paris)"},{"key":"ref22","article-title":"Paraneoplastic Encephalomyelitis","author":"Tirthani E","year":"2025","unstructured":"Tirthani E, Said MS, Smith RG, Jadhav N, Shanina E. Paraneoplastic Encephalomyelitis. StatPearls Publishing, Treasure Island (FL); 2025."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/432868-diagnostic-detour-a-case-of-opsoclonus-myoclonus-ataxia-syndrome-initially-misdiagnosed-as-tricyclic-antidepressant-toxicity-in-a-child","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:29:37Z","timestamp":1767950977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/432868-diagnostic-detour-a-case-of-opsoclonus-myoclonus-ataxia-syndrome-initially-misdiagnosed-as-tricyclic-antidepressant-toxicity-in-a-child"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.101140","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}